Baxter International Inc. (BAX)

74.64
0.90 1.20
NYSE : Health Technology
Prev Close 73.74
Open 74.01
Day Low/High 73.74 / 74.86
52 Wk Low/High 58.81 / 75.62
Volume 1.66M
Avg Volume 3.03M
Exchange NYSE
Shares Outstanding 535.49M
Market Cap 39.27B
EPS 1.30
P/E Ratio 48.56
Div & Yield 0.76 (0.90%)

Latest News

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits

Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits

When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Baxter Highlights Business Strategies And Innovation At 2018 Investor Conference

Baxter Highlights Business Strategies And Innovation At 2018 Investor Conference

Baxter International Inc. (NYSE:BAX), today at its investor conference, outlined the company's strategies to drive sustained growth, deliver attractive shareholder value and advance patient care around the world.

Baxter To Present At The Goldman Sachs Healthcare Conference

Baxter To Present At The Goldman Sachs Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018 in Rancho Palos Verdes, CA.

Baxter To Host 2018 Investor Conference

Baxter To Host 2018 Investor Conference

Baxter International Inc. (NYSE: BAX) will host an investor conference on Monday, May 21, 2018 in New York City at the Pierre Hotel.

Baxter Announces U.S. FDA Clearance Of New Spectrum IQ Infusion System

Baxter Announces U.S. FDA Clearance Of New Spectrum IQ Infusion System

Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the U.

Baxter Declares Dividend And Announces Quarterly Dividend Increase

Baxter Declares Dividend And Announces Quarterly Dividend Increase

Baxter International Inc. (NYSE:BAX) today announced an approximately 19% increase in the company's quarterly dividend rate.

Baxter And The International Society Of Nephrology Announce A Collaboration To Address Growing Prevalence Of Kidney Disease

Baxter And The International Society Of Nephrology Announce A Collaboration To Address Growing Prevalence Of Kidney Disease

Baxter International Inc. (NYSE:BAX), a global innovator in renal (kidney) care, and the International Society of Nephrology (ISN) announced a partnership to advance chronic kidney disease (CKD) awareness and help improve access to therapy, particularly...

Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018

Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018

Baxter International Inc. (NYSE: BAX) today reported results for the first quarter of 2018 and increased its full-year 2018 guidance.

Baxter To Host First Quarter 2018 Financial Results Conference Call For Investors

Baxter To Host First Quarter 2018 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE: BAX), will host a conference call to discuss its first quarter 2018 financial results on Thursday, April 26, 2018, at 7:30 a.

Baxter International Inc. To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. (NYSE:BAX) will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 8, 2018 at 9:00 a.

Mallinckrodt Completes Sale Of RECOTHROM® And PREVELEAK® To Baxter

Mallinckrodt Completes Sale Of RECOTHROM® And PREVELEAK® To Baxter

-- Transaction supports Mallinckrodt's transformation to an innovation-driven specialty pharmaceutical growth company focused on improving outcomes for patients with severe and critical conditions --

Baxter Completes Acquisition Of RECOTHROM And PREVELEAK To Broaden Surgical Hemostat And Sealant Portfolio

Baxter Completes Acquisition Of RECOTHROM And PREVELEAK To Broaden Surgical Hemostat And Sealant Portfolio

Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced it has completed its previously announced acquisition of two hemostat and sealant...

Why Value Investor Benjamin Graham Remains Relevant Today

Why Value Investor Benjamin Graham Remains Relevant Today

I still also use Graham-inspired stock screens, including one based on his 'stocks for the defensive investor' methodology.

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.

Baxter To Present At The Barclays Global Healthcare Conference

Baxter To Present At The Barclays Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Barclays Global Healthcare Conference on Tuesday, March 13, 2018, in Miami, Fla.

Baxter To Present At The Raymond James & Associates 39th Annual Institutional Investors Conference

Baxter To Present At The Raymond James & Associates 39th Annual Institutional Investors Conference

Baxter International Inc. (NYSE: BAX) will present at the Raymond James & Associates 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, in Orlando, Fla.

Baxter Reports 2017 Fourth-Quarter And Full-Year Results

Baxter Reports 2017 Fourth-Quarter And Full-Year Results

Baxter International Inc. (NYSE:BAX) today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.

Baxter To Present At The RBC Capital Markets 2018 Global Healthcare Conference

Baxter To Present At The RBC Capital Markets 2018 Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018, in New York.

Baxter Announces U.S. FDA Approval Of Ready-to-Use Cardiovascular Medication Bivalirudin

Baxter Announces U.S. FDA Approval Of Ready-to-Use Cardiovascular Medication Bivalirudin

Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.

Baxter To Present At The 7th Annual Leerink Partners Global Healthcare Conference

Baxter To Present At The 7th Annual Leerink Partners Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the 7th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 14, 2018, in New York.

Baxter Launches Arisure Closed System Transfer Device To Help Prevent Hazardous Drug Exposure And Maintain Medication Sterility

Baxter Launches Arisure Closed System Transfer Device To Help Prevent Hazardous Drug Exposure And Maintain Medication Sterility

Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced a distribution agreement for the U.

Baxter To Host Fourth Quarter 2017 Financial Results Conference Call For Investors

Baxter To Host Fourth Quarter 2017 Financial Results Conference Call For Investors

Baxter International (NYSE: BAX), will host a conference call to discuss its fourth quarter 2017 financial results on Thursday, February 1, 2018, at 7:30 a.

Baxter Announces Agreement To Broaden Portfolio Of Innovative Surgical Products

Baxter Announces Agreement To Broaden Portfolio Of Innovative Surgical Products

Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced an agreement to acquire two hemostat and sealant products from Mallinckrodt plc:...

Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

-- Sale of hemostasis products reflects further refinement of MNK portfolio and strategy --

Should You Dump Johnson & Johnson for Baxter and Abbott?

Should You Dump Johnson & Johnson for Baxter and Abbott?

While Johnson & Johnson is far from a bad company, there may be more upside in Abbott Laboratories and Baxter International.

Baxter To Present At The 36th Annual J.P. Morgan Healthcare Conference

Baxter To Present At The 36th Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the 36th Annual J.

TheStreet Quant Rating: B+ (Buy)